HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
